Dr. Reddy's Laboratories
RDY
#1635
Rank
A$18.75 B
Marketcap
A$22.50
Share price
0.40%
Change (1 day)
3.26%
Change (1 year)

EPS for Dr. Reddy's Laboratories (RDY)

EPS in 2026 (TTM): A$0.53

According to Dr. Reddy's Laboratories's latest financial reports the company's current EPS (TTM) is A$0.55. In 2025 the company made an earnings per share (EPS) of A$1.18 an increase over its 2024 EPS that were of A$0.94.

EPS history for Dr. Reddy's Laboratories from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$0.53-54.91%
2025A$1.1825%
2024A$0.945.92%
2023A$0.898.45%
2022A$0.8218.06%
2021A$0.6934.06%
2020A$0.5221.94%
2019A$0.42-7.46%
2018A$0.4664.17%
2017A$0.287.49%
2016A$0.26-61.3%
2015A$0.676.44%
2014A$0.63-5.65%
2013A$0.6737%
2012A$0.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.93 1,349.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07 96.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.99 447.00%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
A$4.35 694.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.68 24.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel